Haemostasis in Haemophilia in Relation to the Haemostatic Balance in the Normal Organism and the Effect of Pea Nuts

Tage Astrup; Pieter Brakman; Preben Ollendorff; jørgen Rasmussen

doi:10.1055/s-0038-1654930

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1961; 05(02): 329-340
DOI: 10.1055/s-0038-1654930

Vorläufige Mitteilungen – Preliminary Reports – Communications Préliminaires

Schattauer GmbH

Haemostasis in Haemophilia in Relation to the Haemostatic Balance in the Normal Organism and the Effect of Pea Nuts

Tage Astrup

¹Biological Institute of the Carlsberg Foundation, Copenhagen, Denmark

,

Pieter Brakman

¹Biological Institute of the Carlsberg Foundation, Copenhagen, Denmark

,

Preben Ollendorff

¹Biological Institute of the Carlsberg Foundation, Copenhagen, Denmark

,

jørgen Rasmussen

¹Biological Institute of the Carlsberg Foundation, Copenhagen, Denmark

› Author Affiliations

Abstract

Summary

The problems of haemostasis in haemophiloid patients are considered on the basis of a dynamic equilibrium between fibrin formation and fibrin resolution. It is suggested that the observation by Boudreaux and Frampton of an orally acting haemostatic factor in pea nuts is a result of a delayed fibrin resolution, caused by an antifibrinolytic compound, and not of a restoration of the plasma thromboplastin system (the antihaemophilic factor). This assumption is supported by the results of some preliminary experiments. The haemophiloid disorders represent a deviation in the normal haemostatic balance. For this reason they acquire a broader significance in the study of the physiology and pathology of tissue repair processes than represented by the number of patients carrying these diseases. Some implications concerning the pathogenesis of arteriosclerotic lesions are suggested.

Full Text

References

References
1 Abe T, Sato A. Inhibitory activity of epsilon-amino-caproic acid on fibrinolysis. Seventh European Congress of Haematology; London: Communication 270 1959
2 Ablondi F. B, Hagan J. J, Philips M, De Renzo F. S. Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by epsilon-aminocaproic acid. Arch. Biochem. 82: 153 1959;
3 Alkjaersig N, Fletcher A. P, Sherry S. Epsilon-aminocaproic acid: An inhibitor of plasminogen activation. J. biol. Chem. 234: 832 1959;
4 Astrup T. The biological significance of fibrinolysis. Lancet II: 565 1956;
5 Astrup T. Arteriosclerosis and haemophilia. Lancet II: 745 1957;
6 Astrup T. The haemostatic balance. Thromb. Diath. haem. 02: 347 1958;
7 Astrup T. Role of blood coagulation and fibrinolysis in the pathogenesis of arteriosclerosis. In: Page I. H. Connective tissue, thrombosis and atherosclerosis. 223 Academic Press; New York: 1959
8 Astrup T. Blutgerinnung, Fibrinolyse und Wundheilung. Medizinische 42: 1972 1959;
9 Astrup T, Albrechtsen O. K. Estimation of the plasminogen activator in animal and human tissues. Scand. J. clin. Lab. Inv. 09: 233 1957;
10 Astrup T, Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch. Biochem. 40: 346 1952;
11 Astrup T, Rasmussen J. Estimation of fibrinolytic activity in blood. Proc. 7th International Congress of the International Society of Hematology; Rome: 164 1958
12 Astrup T, Sjolin K-E. Thrombolytic and fibrinolytic activity of human synovial membrane and fibrous capsular tissue. Proc. Soc. exp. Biol. (N. Y.) 97: 852 1958;
13 Balloun S. L, Johnson E. L. Anticoagulant properties of unheated soybean meal in chick diets. Arch. Biochem 42: 355 1953;
14 Borchers R, Ackerson C. W, Kimmell L. Trypsin inhibitor. IV. Occurrence in seeds of the leguminosae and other seeds. Arch. Biochem 13: 291 1947;
15 Borchgrevink Chr. F. Myocardial infarction in a haemophiliac. Lancet I: 1229 1959;
16 Boudreaux Bruce H, Frampton V. L. A peanut factor for haemostasis in haemophilia. Nature (Lond) 185: 469 1960;
17 Heuson J. C, Peers W, Tagnon H. J. A new diagnostic and therapeutic approach to fibrinolysis and haemorrhage. Blood 13: 874 1958;
18 Koutsky K, Hladovec J, Padovec J, Mansfeld V. Über die anti- fibrinolytische Wirkung des aus dem Pankreas sublingual applizierten Inhibitors. Gynaecologia (Basel) 148: 412 1959;
19 Lassen M. Heat dénaturation of plasminogen in the fibrin plate method. Acta physiol. scand. 27: 371 1952;
20 Mann G. V, Andrus S. B, McNally A, Stare F. J. Atherosclerosis in Cebus monkeys. J. exp. Med. 98: 195 1953;
21 Nilsson I. M, Sjoerdsma A, Waldenstrom J. Antifibrinolytic activity and metabolism of epsilon-aminocaproic acid in man. Lancet I: 1322 1960;
22 Ollendorff P. Defects in and variability of the thromboplastic system in horse plasma. Thromb. Diath. haem. 04: 45 1959;
23 Ollendorff P. Initiation of clotting in normal and Hageman plasma by glass. Nature (Lond) 186: 173 1960;
24 Ollendorff P. Platelet activity and activation of blood clotting by glass. Thromb. Diath. haem. 04: 410 1960;
25 Rush Jr B, Cliffton E. E. Control of proteolytic activity in serum. Effect of soybean inhibitor in vivo in the mouse. Amer. J. Physiol. 166: 485 1951;
26 Scroggie A. E, Jaques L. B, Rocha e Silva M. Activation of serum protease in peptone shock. Proc. Soc. exp. Biol. (N. Y.) 66: 326 1947;
26a Sherry S, Fletcher A. P, Alkjaersig N, Sawyer W. D. s-Aminocaproic acid, a potent antifibrinolytic agent. Trans. Ass. Amer. Phycns. 72: 626 1959;
27 Sjølin K-E. A group of AHF deficient patients corrected by adsorbed serum. Trans. 6th Congress Europ. Soc. Haemat. Copenhagen.. 576 Karger; Basel: 1957
28 Sjolin K-E. Variations of the coagulation defects in haemophilia. 7th Congr. Internat. Soc. Haemat., Rome. Abstracts 287 1958;
29 Steiner A, Dayton S. Production of hyperlipemia and early atherosclerosis in rabbits by a high vegetable fat diet. Circulat. Res. 04: 62 1956;